| # | % | |||||
|---|---|---|---|---|---|---|
| 401 | NOVADAQ TECHNOLOGIES INC | 14,000 | 162,000 | 0.01% | ||
| 402 | ALIMERA SCIENCES INC | 85,000 | 127,000 | 0.01% | ||
| 403 | CERUS CORP | 20,000 | 124,000 | 0.01% | ||
| 404 | AMICUS THERAPEUTICS INC COM | 10,000 | 74,000 | 0.00% | ||
| 405 | CATALYST PHARMACEUTICALS INC | 68,000 | 74,000 | 0.00% | ||
| 406 | ONCONOVA THERAPEUTICS INC | 24,087 | 64,000 | 0.00% | ||
| 407 | GERON CORP | 20,000 | 45,000 | 0.00% | ||
| 408 | ROKA BIOSCIENCE INC | 54,000 | 38,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001062574-16-000018, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
